Powder: -20°C for 3 years | In solvent: -80°C for 1 year
TNO155 is a protein tyrosine phosphatase (PTP) non-receptor type 11 (SHP2; src homology region 2 domain phosphatase; PTPN11) inhibitor(IC50 : 0.011 μM),with potential antineoplastic activity.
説明 | TNO155 is a protein tyrosine phosphatase (PTP) non-receptor type 11 (SHP2; src homology region 2 domain phosphatase; PTPN11) inhibitor(IC50 : 0.011 μM),with potential antineoplastic activity. |
ターゲット&IC50 | SHP2:0.011 µM |
別名 | Batoprotafib |
分子量 | 421.95 |
分子式 | C18H24ClN7OS |
CAS No. | 1801765-04-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/mL (130.35 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
TNO155 1801765-04-7 Metabolism Phosphatase Aberrant BCS NSCLC Batoprotafib SHP2 TNO 155 Inhibitor malignancy CRC inhibit allosteric TNO-155 EGFR-mutant RTK-dependent HNSCC activation inhibitor